Table 2.
Osteoporosis treatment for patients identified as high-risk for glucocorticoid-induced osteoporosis.
| Prescribed no. (%) | |
|---|---|
| Osteoporosis treatment | 56 (93) |
| Bisphosphonates | 30 (50) |
| With active vitamin D3 | 15 (25) |
| Without active vitamin D3 | 15 (25) |
| Teriparatide | 3 (5) |
| Denosumab with vitamin D3 | 12 (20) |
| Active vitamin D3 monotherapy | 11 (18) |
| Alfacalcidol | 7 (12) |
| Eldecalcitol | 4 (6) |
| Untreated | 4 (6) |